New mesothelioma treatment shows initial success
According to Nashville-based Neoplas Innovation, the first mesothelioma patient to be treated with its new treatment protocol has responded favorably. The treatment protocol, which has been tested on a number of other aggressive cancers, involves a combination of low-dose interferon and lovastatin.
This initial test patient was not been helped by standard mesothelioma treatments. And although her response to the new treatment has been favorable, the response of a single patient is not enough information to draw any conclusions about the treatment’s clinical effectiveness.
The two drugs that are being used in the treatment protocol are existing drugs being used in a new, “off-label” way. Lovastatin is generally used to lower cholesterol. More than ten years ago, lovastatin was shown to attack mesothelioma cells in lab cultures.
Learn more from NeoPlas Innovation’s Press Release.
![[Information package]](http://www.mesotheliomanews.com/wp-content/themes/biromeso/images/infopack.jpg)
